With 21 years of experience across a breadth of therapeutic areas, SQN have been established as one of the largest specialist biometric CRO’s in Europe.

Striving for continued success, we are driving innovation to change the way clinical research is conducted. With an effective focus on patient care, our technology ensures advanced sponsor oversight, ultimately saving time and cost while accelerating regulatory approvals.

 EDC

 ePRO

 Analytics

Driving innovation in clinical research

Data management
Statistics
CRF/eCRF design
EDC systems deployment and support
ePRO and patient centric data
Trial Management and data analytics

Medical writing
ISS/ISE CDISC data integration
Project management
Clinical services
QA audits and Consultancy

Syne qua non Ltd
Gostling House
Diss Business Park
Hopper Way, Diss
Norfolk IP22 4GT, UK

T +44 (0)1379 644449
E info@synequanon.com

Analytics and Dashboard

  • Supports robust project management and clinical oversight
  • Real-time access to current project status and risks
    • Enhanced safety oversight and escalation
    • Early triggers for site performance issues
    • Easy visibility of key metrics
    • Rapid review CRF data
    • Patient profiles
  • Incorporating AI technology
  • Access via mobile device
  • Download reports to excel
  • Bespoke reports can be produced
  • Ability to drill down into the data

Contact Us

ePRO Overview


  • Real time data collection, patients can capture how they feel on a day-to-day basis wherever they may be.
  • Better interaction between patient and site through technology enabled messaging functionality, reminders and alerts.
  • Collection of wellness data additionally to protocol data for better insight and treatment trends.
  • Centralised patient oversight and safety monitoring
  • Driving compliance as the FDA looks for patient centric data collection.

Contact Us

EDC Overview

  • Fully validated, SQN-developed EDC system. Meeting US FDA and UK MHRA guidelines.
  • Compliant with EU 2005/28/EC, UK Statutory Instrument 1031, Medicines for Human Use Regulations, EMA Electronic Records,  21 CFR Part 11 and ICH Good Clinical Practice
  • Rapid setup via library of validated, CDISC based modules (6 -12 weeks from final protocol)
  • Intuitive user interface with look and feel of paper; minimal training and helpdesk support required
  • Integrated data collection, SDV, query, data management and Investigator sign-off
  • Used extensively by Biotechnology, Global Pharma and other CRO companies across all study phases

Contact Us

Go to article: Home | Unlocking the potential of Chinese medicineGo to article: In This IssueGo to article: BrooksGo to article: ContentsGo to article: NewsGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: Could focusing on the user experience reinvent drug R&D software?Go to article: EcocoolGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Pharma Support Services LtdGo to article: Pharma Support Services Ltd Company InsightGo to article: US drug pricing: could the industry regulate itself?Go to article: Gerresheimer AG Go to article: Unlocking the potential of Chinese medicineGo to article: Pfanstiehl, IncGo to article: Scandinavian Health LtdGo to article: Inside Canada’s centre for drug research and developmentGo to article: Scandinavian Health Ltd Company InsightGo to article: Award-winning pharma packagingGo to article: MalvernGo to article: Dividella AGGo to article: EventsGo to article: Event: CPhI ChinaGo to article: Next IssueGo to article: LaudaGo to article: DJAGo to article: ILC Dover IncGo to article: TemptimeGo to article: HaselmeierGo to article: Haselmeier AdvertorialGo to article: Syne Qua Non LtdGo to article: Gerteis